Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 12;10:343. doi: 10.3389/fonc.2020.00343

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Cantini, Hassan, Sterman and Aerts.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Potential targets of emerging therapies for malignant pleural mesothelioma. ASSI, argininosuccinate synthase I; CAR, chimeric antigen receptor; CD80, cluster of differentiation 80; CD86, cluster of differentiation 86; CDK4/6, cyclin-dependent kinase 4/6; CTLA-4, cytotoxic T lymphocyte associated protein-4; EZH2, enhancer of zeste homolog 2; PARP, poly ADP ribose polymerase; PD-1, programmed cell death-1; PD-L1, programmed death ligand-1; TAAs, tumor-associated antigens; TKI, tyrosine kinase inhibitor; TTF, tumor-treating fields; VEGFR, vascular endothelial growth factor receptor.